Clinical Innovation Fund
Forecasted
Clinical Innovation Fund supports researchers developing innovative approaches to organ and tissue donation and transplantation to improve recipient outcomes and reduce the need for transplantation.
Browse similar grants
Funder: Mid-America Transplant Foundation
Due Dates (Anticipated): February 2027 (Letter of Inquiry)
Funding Amounts: Up to $150,000 per year for three years; maximum total award of $450,000
Summary: Supports innovative research to improve organ and tissue donation and transplantation outcomes and reduce the need for transplantation.
Key Information: Applicants must be 501(c)(3) nonprofit corporations within Mid-America Transplant’s donation service area.
Description
The Clinical Innovation Fund, administered by Mid-America Transplant Foundation, supports research addressing critical clinical issues in organ and tissue transplantation. Since 2016, the fund has backed projects intended to improve donation and transplantation outcomes while honoring the gifts of donors and their families. Its goals include reducing the need for transplantation, increasing the availability of organs and tissues, and improving health and financial outcomes for transplant recipients.
The program seeks innovative solutions with measurable impact. Research interests include patient-oriented research, outcomes research, and health services studies. Special consideration goes to projects that increase organ utilization through deceased donor management, Donation after Circulatory Death (DCD), lower kidney discard rates, and greater use of marginal or extended criteria organs. Bioengineering and regenerative medicine applications with potential to significantly affect transplantation are strongly encouraged.
